Form 8-K - Current report:
SEC Accession No. 0000950170-23-029423
Filing Date
2023-06-22
Accepted
2023-06-22 16:30:54
Documents
13
Period of Report
2023-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20230621.htm   iXBRL 8-K 132391
2 EX-10.1 drrx-ex10_1.htm EX-10.1 223710
  Complete submission text file 0000950170-23-029423.txt   505995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20230621_pre.xml EX-101.PRE 10669
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20230621_lab.xml EX-101.LAB 17029
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20230621.xsd EX-101.SCH 2468
7 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20230621_htm.xml XML 4508
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 231033702
SIC: 2834 Pharmaceutical Preparations